Lasergene genomics suite site license

Ended Purchase Order Awarded Last action

Contract number
W81XWH20P0166
Awardee
Awarding agency
Obligated
$107,500

Award facts

Opportunity
Contract value 100% obligated
$107,500.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
511210 Software Publishers
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Madison, WI 53705, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00007 · Lasergene GEN suite site license $22,500
Other Administrative Action P00006 $0
Exercise an Option P00005 · Lasergene GEN suite site LIC option YR 3 $22,000
Other Administrative Action P00004 · Lasergene general suite in genomics per section 711 of the 2019 ndaa, usamraa transferred to DHA 10/1/2022. $0
Exercise an Option P00003 · Lasergene GEN suite site license $21,500
Exercise an Option P00002 · Lasergene GEN suite site LIC option YR 1 exercise. $21,000
Supplemental Agreement for work within scope P00001 · Admin MOD to add clause 52.204-25(AUG 2020) $0
Original award $20,500

About this award

This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to DNASTAR, Inc., a for-profit Subchapter S corporation, for a Lasergene Genomics Suite site license. The contract has a ceiling value of $107,500.00 and a period of performance through August 27, 2025.

The contract was awarded as a sole-source acquisition under FAR 13.106-1(b)(1)(i) as DNASTAR is the sole developer, manufacturer, and distributor of the Lasergene Genomics Suite software, which is required by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) for next-generation sequencing assembly and analysis, clinical research, and traditional sequence analysis. No set-aside designation was used for this award.

Quick answers

Who was awarded contract W81XWH20P0166?

W81XWH20P0166 was awarded to Dnastar, Inc. by Defense Health Agency (Department of Defense) on August 28, 2020.

How much is contract W81XWH20P0166 worth?

The government has obligated $107,500 on W81XWH20P0166.

Was contract W81XWH20P0166 competed?

The extent of competition for W81XWH20P0166 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award